A novel application of Transnasal Humidified Rapid Insufflation Ventilatory Exchange via the oral route in morbidly obese patient during monitored anesthesia care - A case report.
Anesth Pain Med (Seoul)
; 15(4): 505-509, 2020 Oct 30.
Article
en En
| MEDLINE
| ID: mdl-33329856
BACKGROUND: Transnasal Humidified Rapid Insufflation Ventilatory Exchange (THRIVE) is used to improve oxygenation, with the added benefit of a smaller increase in CO2 if self-respiration is maintained with THRIVE. Despite these advantages, the use of THRIVE through a nasal cannula is limited in situations such as epistaxis or a basal skull fracture. CASE: We successful used THRIVE, through the oral route under general anesthesia with spontaneous breathing in a morbidly obese patient (weight, 148 kg; height, 183 cm; body mass index, 44.2 kg/m2) who received transnasal steroid injections due to subglottic stenosis. CONCLUSIONS: THRIVE through the oral route may be an effective novel option, although further studies are needed.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Anesth Pain Med (Seoul)
Año:
2020
Tipo del documento:
Article
Pais de publicación:
Corea del Sur